Differential low uptake of free vitamin D supplements in preterm infants: the Quebec experience

BMC Pediatrics
|December 1, 2014
PubMed

Insights

Vitamin D supplement uptake was low among preterm infants in Quebec, decreasing over time and varying by gestational age. Targeting interventions towards late preterm infants and younger mothers could improve vitamin D supplementation rates.

Area of Science:

  • Neonatal Health
  • Public Health Policy
  • Nutritional Science

Background:

  • Vitamin D is crucial for bone health in premature infants.
  • Quebec's public health insurance (Régie de l'Assurance Maladie du Québec - RAMQ) provides free vitamin D supplements.
  • Understanding supplement uptake is vital for optimizing infant nutrition.

Purpose of the Study:

  • To assess vitamin D supplement acquisition by preterm infants through the RAMQ program.
  • To analyze variations in supplement uptake based on gestational age.
  • To identify factors influencing participation and adherence to vitamin D supplementation.

Main Methods:

  • Retrospective cohort study of preterm infants (1998-2008) covered by RAMQ.
  • Data linkage from the Quebec Pregnancy Cohort administrative database.
  • Stratification by early (<34 weeks) and late gestational age; logistic regression for predictor analysis.

Main Results:

  • 24.5% of 10,288 eligible preterm infants received vitamin D; uptake was higher in early preterms (37.4%) vs. late preterms (20.7%).
  • Median supplement bottles obtained were 2 for early and 1 for late preterm infants.
  • Program participation declined annually (OR=0.90/year), with higher uptake associated with older/educated mothers and pediatrician prescriptions.

Conclusions:

  • Vitamin D supplement uptake by preterm infants was low and decreased over the first year post-discharge.
  • Early preterm infants showed higher initial acquisition rates than late preterm infants.
  • Intervention strategies should consider targeting late preterm infants and mothers with lower educational attainment to enhance vitamin D supplementation.
Abstract

Related Concept Videos

Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
9.1K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
944
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
895
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
518
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
393
Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
3.2K